
Nymox Pharmaceutical Corporation NYMX
Annual report 2024
added 02-21-2026
Nymox Pharmaceutical Corporation Long Term Debt Current 2011-2026 | NYMX
Annual Long Term Debt Current Nymox Pharmaceutical Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 23 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 23 K | 23 K | 23 K |
Long Term Debt Current of other stocks in the Biotechnology industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | ||
|
Autolus Therapeutics plc
AUTL
|
5.05 M | $ 1.68 | 2.44 % | $ 429 M | ||
|
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | ||
|
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | ||
|
Kamada Ltd.
KMDA
|
1.63 M | $ 8.81 | 1.73 % | $ 260 M | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Adagene
ADAG
|
1.18 M | $ 3.26 | 0.62 % | $ 183 M | ||
|
Alterity Therapeutics Limited
ATHE
|
57.6 K | $ 3.28 | -2.62 % | $ 7.89 B | ||
|
Evogene Ltd.
EVGN
|
589 K | $ 0.81 | -9.28 % | $ 27.9 M | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | ||
|
Aptorum Group Limited
APM
|
433 K | $ 0.79 | -1.29 % | $ 4.31 M | ||
|
Alpine Immune Sciences
ALPN
|
756 K | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
10.8 M | - | 4.14 % | $ 49.1 M | ||
|
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Aptose Biosciences
APTO
|
428 K | - | -45.71 % | $ 1.2 M | ||
|
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | ||
|
Ascendis Pharma A/S
ASND
|
14.2 M | $ 224.42 | -2.52 % | $ 5 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
Athersys
ATHX
|
1.01 M | - | 3.77 % | $ 22.4 M | ||
|
AVROBIO
AVRO
|
878 K | - | 1083.1 % | $ 745 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | ||
|
Aytu BioScience
AYTU
|
137 K | $ 2.36 | 2.27 % | $ 14.8 M | ||
|
Aptinyx
APTX
|
337 K | - | -39.0 % | $ 4.57 M | ||
|
AstraZeneca PLC
AZN
|
339 M | - | - | $ 96.9 B | ||
|
Aridis Pharmaceuticals
ARDS
|
538 K | - | 17.91 % | $ 11.1 M | ||
|
Brickell Biotech
BBI
|
49 K | - | -5.38 % | $ 6.06 M | ||
|
Codexis
CDXS
|
2.83 M | $ 1.17 | -0.85 % | $ 85.9 M | ||
|
Athira Pharma
ATHA
|
414 K | - | - | $ 269 M | ||
|
BioNTech SE
BNTX
|
39.5 M | $ 110.12 | -0.28 % | $ 27.2 B | ||
|
Amneal Pharmaceuticals
AMRX
|
224 M | $ 14.49 | -0.75 % | $ 4.48 B | ||
|
AIkido Pharma
AIKI
|
410 K | - | 1.93 % | $ 17.4 M | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M |